Loading…
Long-term Stability of Human Aflatoxin B1 Albumin Adducts Assessed by Isotope Dilution Mass Spectrometry and High-Performance Liquid Chromatography–Fluorescence
The measurement of the aflatoxin B 1 -lysine serum albumin adduct in human blood samples is the most facile biomarker for the assessment of chronic exposure to aflatoxin B 1 . Many technologies have been developed for the measurement of this protein adduct including immunoassays, high-performance li...
Saved in:
Published in: | Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2008-06, Vol.17 (6), p.1436-1439 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The measurement of the aflatoxin B 1 -lysine serum albumin adduct in human blood samples is the most facile biomarker for the assessment of chronic exposure to
aflatoxin B 1 . Many technologies have been developed for the measurement of this protein adduct including immunoassays, high-performance
liquid chromatography (HPLC) with fluorescence detection, and a newly developed isotope-dilution mass spectrometry method.
Irrespective of the technology used to determine this adduct level, an important question remains about the long-term stability
of this damage product in stored samples. To address this issue, 19 human serum samples that had been previously analyzed
for the aflatoxin B 1 -lysine adduct by high-performance liquid chromatography–fluorescence in 1989 were re-analyzed by isotope dilution mass spectrometry
after storage at −80°C. The adduct concentrations measured by these two techniques were identical within 4% over the range
5 to 100 pg of aflatoxin B 1 -lysine/mg albumin. In addition, the specific chemical structure of the aflatoxin B 1 -lysine adduct in human samples was confirmed for the first time by collision-induced dissociation full scan mass spectrometry
analysis of the protonated adduct molecular ion. These results illustrate that the aflatoxin B 1 -lysine serum albumin adduct can be stable in human serum stored at −80°C since 1989, and this provides confidence for the
measurement of this biomarker in repository samples from epidemiologic investigations. (Cancer Epidemiol Biomarkers Prev 2008;17(6):1436–9) |
---|---|
ISSN: | 1055-9965 1538-7755 |
DOI: | 10.1158/1055-9965.EPI-07-2926 |